Edit
Sanofi Genzyme
https://www.sanofigenzyme.com/Last activity: 20.06.2024
Active - Reference to Sanofi
This Facebook page is intended for a Global audience.
Thank you for taking the time to visit our page. We look forward to hearing from you! Sanofi Genzyme uses Facebook as a channel to communicate with our customers and other members of the Facebook community. All users must comply with Facebook's Terms of Use and Sanofi Genzyme's Rules of Engagement (http://bit.ly/30ISzTN).
Thank you for taking the time to visit our page. We look forward to hearing from you! Sanofi Genzyme uses Facebook as a channel to communicate with our customers and other members of the Facebook community. All users must comply with Facebook's Terms of Use and Sanofi Genzyme's Rules of Engagement (http://bit.ly/30ISzTN).
Location: United States, New Jersey, Princeton
Employees: 5001-10000
Founded date: 1981
Investors 1
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
Mentions in press and media 7
| Date | Title | Description |
| 20.06.2024 | Azzur Group Appoints Nick Mazzucca as Vice President of Sales and Marketing | HATBORO, Pa., June 20, 2024 /PRNewswire/ -- Azzur Group, a comprehensive solutions provider for life science innovators in the regulated space, is excited to announce the appointment of Nick Mazzucca as Vice President of Sales and Marketing... |
| 14.03.2024 | Rare Disease Advocates Learn to Accelerate Therapeutic Development at 9th RARE Drug Development Symposium | RARE Drug Development Symposium The RARE Drug Development Symposium, hosted by Global Genes and the Orphan Disease Center of the University of Pennsylvania, equips advocates with the knowledge, skills and connections they need to advance th... |
| 11.06.2018 | In the heart of one of the biggest Life Sciences hubs - tales from a Swiss entrepreneur in Boston | In the heart of one of the biggest Life Sciences hubs - tales from a Swiss entrepreneur in Boston 11.06.2018 09:00, Charlotte Pichon linkedIn facebook twitter instagram youtube --> Venture Leaders Life Sciences team member Mathieu Horras... |
| 04.10.2017 | Why designing patient-centered clinical trials is like conducting an orchestra | “Our trials are very long, sometimes five years, just because of the rarity of disease,” said Tan. “Participating in a clinical trial takes a lot of commitment that impedes family life, work life — some patients have said they’ve lost jobs ... |
| 30.03.2016 | Sanofi Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round | ImmuneXcite CEO Eric Furfine ImmuneXcite has raised $8.6 million in a Series A financing round as the immuno-oncology biotech announced the addition of Glaxo ($GSK) and Sanofi Genzyme ($SNY) veterans to its executive crew. The Lexington, MA... |
| - | Why designing patient-centered clinical trials is like conducting an orchestra | What tends to become lost in the course of developing clinical trials is the voice of the patient — something Sharon Tan knows all too well. As global project head of Sanofi Genzyme, Tan works with the Massachusetts-based company’s in-house... |
| - | Building on a legacy of enzyme replacement therapy to fuel rare disease treatment | As the name implies, a rare disease is an illness that affects far fewer people than more common conditions, like breast cancer or heart disease. Today, however, 7,000 rare conditions have been identified, and these affect more than 350 mil... |